Indication

Pyoderma gangrenosum

Pyoderma gangrenosum is a rare, non-infectious inflammatory cutaneous disorder classified within the spectrum of neutrophilic dermatoses. Read more about Pyoderma gangrenosum

833 drugs 198 manufacturers

Advertisement

Drugs that treat it

Common Pyoderma gangrenosum therapies.

Showing 496–504 of 833 drugs

FLUOCINONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
LUPIN PHARMACEU

FLUOCINONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
SOLA PHARMACEUT

FLUOCINONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
LUPIN PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Pyoderma gangrenosum preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pyoderma gangrenosum.

Pyoderma gangrenosum is a rare, non-infectious inflammatory cutaneous disorder classified within the spectrum of neutrophilic dermatoses.

It primarily affects adults—most commonly in their 30s to 50s—and frequently occurs alongside systemic autoimmune conditions such as inflammatory bowel disease, rheumatoid arthritis, or hematologic malignancies.

Pathophysiologically driven by immune dysregulation, neutrophil dysfunction, and aberrant cytokine signaling, the condition is clinically characterized by painful, rapidly progressing skin pustules or nodules that break down into destructive ulcers with classic violaceous, undermined borders.

Personalize your experience

Follow Pyoderma gangrenosum and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it